Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2022-06-17 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Record Date
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 171 characters, indicating it is extremely short and contains no report content. There is no indication of any report, announcement, or filing type. Given the lack of content, the document cannot be classified as a report or announcement and falls under the fallback category for miscellaneous filings.
2022-06-17 English
General updates
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for images and no textual content or substantive information. It is extremely short (171 characters) and does not contain any report, announcement, or regulatory information. Given the lack of content, it cannot be classified as any specific report or announcement type. According to the rules, such documents fall under the fallback category of Regulatory Filings (RNS).
2022-06-17 English
Newspaper Advertisements
Regulatory Filings
2022-06-11 English
Loss of share certificate
Major Shareholding Notification Classification · 95% confidence The document contains a table listing shareholder information including folio number, shareholder name, number of shares, distinctive numbers, and date of receipt of information by the company. The content is very brief (369 characters) and appears to be a notification of shareholding details rather than a full report or announcement of a meeting or financial results. There is no indication of a meeting, voting results, financial data, or management changes. This fits the description of a Major Shareholding Notification, which reports changes in significant share ownership levels or shareholder details.
2022-06-08 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 90% confidence The document is extremely short (333 characters) and contains no substantive financial data or detailed content. It appears to be an invitation or announcement related to an event (Annual Trinity India Conference) with a date and place mentioned. There is no indication of financial results, management changes, or regulatory filings. Given the brevity and nature, it is likely an announcement related to an event or meeting, but not a full report or transcript. The best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous short announcements that do not fit other categories.
2022-06-01 English
Related Party Transaction
Regulatory Filings Classification · 95% confidence The document is a submission to the National Stock Exchange of India regarding a half yearly disclosure on Related Party Transactions pursuant to SEBI Listing Regulations. It references the half year ended March 31, 2022, and contains detailed disclosure tables about related party transactions, including loans, remuneration, and balances. The content is regulatory in nature, focused on compliance with listing obligations and disclosure requirements, specifically related to related party transactions for a half-year period. This type of document is a regulatory filing that provides compliance information rather than a full financial report or earnings release. It is not an Annual Report, Interim Report, or Earnings Release, but a regulatory disclosure filing. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-06-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.